News

NOV-FEBPS Anti-Cancer Symposium

2013-12-042,793

“NOV-FEBPS Anti-Cancer Symposium –   Practical approaches to develop anticancer drug with high impact ability”

 

When: 2013, 12, 4 (Wed), 8:30 am – 7 pm

Where: Textile Center Building (Sky Hall, 17th floor), Gangnam-Gu, Daechi-Dong, 944-31, Seoul, Korea

Program

8:30 – 9:00: Registration

9:00 – 9:20: Welcome Address: Dr. In-Chull Kim, CEO & President, NOV

 

Session 1   Chair: Dr. Jung-Yong Kim, National Cancer Center

 

9:20 – 10:00    Bringing Best Oncology Medicines to Asian Patients: A Mission Possible! Dr. Bin Peng ( Novartis Institutes for BioMedical Research, China)

10:00 – 10:40    Emerging Challenges in Global Cancer Clinical Trials

                          Dr. Sun Young Rha (Yonsei University College of Medicine, Korea)

 

10:40 – 11:00 Coffee Break

 

Session 2   Chair: Dr. Young-Hwa Kim, Astra Zeneca

 

11:00 – 11:40    Drug Development for Gastric and Liver Cancer Lessons Learned                        Dr. Christine Dela Cruz ( BMS, Singapore)

11:40 12:20    Practical Statistical Issues and Challenges in Cancer Clinical Trials

Dr. Byung-Ho Nam (National Cancer Center, Korea)

 

12:20 12:30 Group Photo

12:30 – 1:30   Lunch

 

Session 3   Chair: Mr. Hak-Bae Choi, JW Pharmaceutical Co

 

1:30 – 2:10        Personalized Healthcare (PHC) Accelerates Innovation in Cancer Treatment

                           Dr. Hisanori Takanashi (Chugai Pharmaceutical, Japan)

2:10 2:50     Paradigm of drug development of oncology in the era of Precision Medicine

                          Dr. Sang-Yoon Lee (Pfizer, Japan and Korea)

 

2:50 – 3:10   Coffee Break

 

Session 4   Chair: Dr. Jin-Keon Pai, Handok Pharmaceuticals Co.

 

3:10 – 3:50    Ras destabilization via the Wnt/beta-catenin signaling, and development of anti-cancer drugs Inhibiting both Wnt/beta-catenin and Ras signaling

Dr. Kang-Yell Choi ( Yonsei University, Korea)

3:50 – 4:30    Japan-Korea Collaborative Study of Nimotuzumab for Gastric Cancer

Dr. Masanori Suzuki (Daiichi Sankyo, Japan)

4:30 – 5:00    Challenges in Anti-Cancer Drug R&D

Dr. Moon-Hwan Kim ( National OncoVenture, Korea)

5:00 – 5:15 Closing remark: Dr. Chong-Hwan Chang, President, Osong New Drug Development Center

5:15 – 7:00 Dinner